Cytosorbents Corp
CTSO
96 hedge funds and large institutions have $136M invested in Cytosorbents Corp in 2020 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 36 increasing their positions, 19 reducing their positions, and 14 closing their positions.
89% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 19
43% more first-time investments, than exits
New positions opened: 20 | Existing positions closed: 14
22% more capital invested
Capital invested by funds: $111M → $136M (+$24.8M)
8.72% more ownership
Funds ownership: 31.12% → 39.84% (+8.7%)
5% more funds holding
Funds holding: 91 → 96 (+5)
22% less call options, than puts
Call options by funds: $593K | Put options by funds: $760K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
+$19M |
| 2 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$14.7M |
| 3 |
Neuberger Berman Group
New York
|
+$5.26M |
| 4 |
BlackRock
New York
|
+$3.68M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.74M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EI
EAM Investors
Solana Beach,
California
|
-$1.63M |
| 2 |
EGI
EAM Global Investors
Solana Beach,
California
|
-$1.13M |
| 3 |
Squarepoint
New York
|
-$840K |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$729K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$412K |
CTSO Hedge Fund Activity: Q3 2020 in Review
96 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q3 2020, worth a combined $136M — up 22% from $111M a quarter earlier.
Buyers outnumbered sellers: 20 funds opened new CTSO positions and 14 closed out — a net gain of 6 holders — while 36 added to existing stakes and 19 trimmed.
The largest buyer was Redmile Group, opening a new position worth an estimated $19M. The largest seller was EAM Investors, exiting entirely with an estimated $1.63M sold.
- 96 institutional investors held Cytosorbents Corp (CTSO) as of Q3 2020, up from 91 in Q2 2020.
- Funds reported $136M of Cytosorbents Corp stock for Q3 2020, up 22% quarter-over-quarter.
- 20 funds opened new Cytosorbents Corp positions in Q3 2020 and 14 closed out, a net change of +6 holders.
- The largest Cytosorbents Corp buyer in Q3 2020 was Redmile Group, an estimated $19M added.
- The largest Cytosorbents Corp seller in Q3 2020 was EAM Investors, an estimated $1.63M sold.
Based on aggregated 13F filings for Q3 2020.